← FDA Drug Approvals (Drugs@FDA)
CARBIDOPA AND LEVODOPA
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA LTD · Approved 2022-11-28
Drug application
- FDA Application #
ANDA216537
- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- CARBIDOPA AND LEVODOPA
- Generic name
- CARBIDOPA AND LEVODOPA
- Active ingredients
- CARBIDOPA; LEVODOPA
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- AUROBINDO PHARMA LTD
- Manufacturer
- Aurobindo Pharma Limited
- First approval
- 2022-11-28
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown